Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Corona Virus Disease 2019

Reda Bzikha, Bouhmou Ayoub, Bzikha Ilham, S. Bouchnafati
{"title":"Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Corona Virus Disease 2019","authors":"Reda Bzikha, Bouhmou Ayoub, Bzikha Ilham, S. Bouchnafati","doi":"10.35248/1948-5964.20.S6.002","DOIUrl":null,"url":null,"abstract":"Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV aswell as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.","PeriodicalId":15020,"journal":{"name":"Journal of Antivirals & Antiretrovirals","volume":"47 1","pages":"1-2"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Antivirals & Antiretrovirals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35248/1948-5964.20.S6.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2

Abstract

Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19). Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV aswell as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
瑞德西韦和洛匹那韦/利托那韦作为治疗冠状病毒病的潜在药物2019
对SARS-CoV-2有效的药物尚未确定。瑞德西韦和洛匹那韦/利托那韦因其治疗2019冠状病毒病(COVID-19)的潜力而引起了相当大的关注。瑞德西韦不仅在体内,而且在体外测试中都显示出对人类冠状病毒复制的抑制作用,包括SARS-CoV以及洛匹那韦/利托那韦,后者显示出对SARS-CoV-2有希望的抗病毒药物。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
siRNA-Inhibition of TIGAR Hypersensitizes Human Papillomavirus-Transformed Cells to Apoptosis Induced by Chemotherapy Drugs that Cause Oxidative Stress Coroless, effective ingredient isolated from traditional Chinese medicine for the prevention and treatment of Covid-19 An Exploratory Study on COVID-19 and the Rights of Children Based on Keyword Network Analysis Comorbidities of COVID-19 Patients with Low Cycle Threshold (Ct) Value of Nucleocapsid (N) Gene: An Application to Cluster-Based Logistic Model. A Questionnaire-Based Survey to Assess the Timing of Intubation in COVID-19 Pneumonia.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1